CN110892987A - Preparation method of wolfberry syrup - Google Patents
Preparation method of wolfberry syrup Download PDFInfo
- Publication number
- CN110892987A CN110892987A CN201911210590.XA CN201911210590A CN110892987A CN 110892987 A CN110892987 A CN 110892987A CN 201911210590 A CN201911210590 A CN 201911210590A CN 110892987 A CN110892987 A CN 110892987A
- Authority
- CN
- China
- Prior art keywords
- fructus lycii
- medlar
- zeaxanthin
- pulp
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020357 syrup Nutrition 0.000 title claims abstract description 40
- 239000006188 syrup Substances 0.000 title claims abstract description 40
- 235000015459 Lycium barbarum Nutrition 0.000 title claims description 41
- 235000015468 Lycium chinense Nutrition 0.000 title claims description 36
- 244000241838 Lycium barbarum Species 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 169
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 169
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 169
- XACHQDDXHDTRLX-XLVVAOPESA-N Physalien Chemical compound CC1(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-XLVVAOPESA-N 0.000 claims abstract description 156
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 claims abstract description 156
- XACHQDDXHDTRLX-UHFFFAOYSA-N Zeaxanthin-dipalmitat Natural products CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-UHFFFAOYSA-N 0.000 claims abstract description 156
- 238000000605 extraction Methods 0.000 claims abstract description 133
- 239000000284 extract Substances 0.000 claims abstract description 103
- 239000007788 liquid Substances 0.000 claims abstract description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000002994 raw material Substances 0.000 claims abstract description 37
- 238000001914 filtration Methods 0.000 claims abstract description 20
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 16
- 229930003944 flavone Natural products 0.000 claims abstract description 16
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 16
- 235000011949 flavones Nutrition 0.000 claims abstract description 16
- 239000012466 permeate Substances 0.000 claims abstract description 16
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002244 precipitate Substances 0.000 claims abstract description 14
- 239000011347 resin Substances 0.000 claims abstract description 14
- 229920005989 resin Polymers 0.000 claims abstract description 14
- 238000005342 ion exchange Methods 0.000 claims abstract description 8
- 244000182216 Mimusops elengi Species 0.000 claims description 158
- 239000000843 powder Substances 0.000 claims description 59
- 239000003094 microcapsule Substances 0.000 claims description 56
- 239000003795 chemical substances by application Substances 0.000 claims description 44
- 238000001035 drying Methods 0.000 claims description 41
- 244000241872 Lycium chinense Species 0.000 claims description 35
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 28
- 238000004537 pulping Methods 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 24
- 229930013930 alkaloid Natural products 0.000 claims description 15
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 15
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 14
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 claims description 14
- 239000003915 liquefied petroleum gas Substances 0.000 claims description 14
- 239000001273 butane Substances 0.000 claims description 12
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 12
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- 238000004458 analytical method Methods 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 8
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims description 7
- 108010059892 Cellulase Proteins 0.000 claims description 7
- 229910018503 SF6 Inorganic materials 0.000 claims description 7
- 229940106157 cellulase Drugs 0.000 claims description 7
- 238000011033 desalting Methods 0.000 claims description 7
- 239000001282 iso-butane Substances 0.000 claims description 7
- 239000001294 propane Substances 0.000 claims description 7
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 claims description 7
- 229960000909 sulfur hexafluoride Drugs 0.000 claims description 7
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 239000003480 eluent Substances 0.000 claims 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 239000001569 carbon dioxide Substances 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 2
- 240000002624 Mespilus germanica Species 0.000 abstract 11
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 136
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 114
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 114
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 114
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 114
- 235000010930 zeaxanthin Nutrition 0.000 description 114
- 239000001775 zeaxanthin Substances 0.000 description 114
- 229940043269 zeaxanthin Drugs 0.000 description 114
- 240000007594 Oryza sativa Species 0.000 description 51
- 235000007164 Oryza sativa Nutrition 0.000 description 51
- 235000009566 rice Nutrition 0.000 description 51
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 36
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 33
- 238000002156 mixing Methods 0.000 description 32
- 239000006187 pill Substances 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- 239000006228 supernatant Substances 0.000 description 24
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 24
- 235000013361 beverage Nutrition 0.000 description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 22
- 235000012680 lutein Nutrition 0.000 description 22
- 239000001656 lutein Substances 0.000 description 22
- 229960005375 lutein Drugs 0.000 description 22
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 22
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 22
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 22
- 229920002472 Starch Polymers 0.000 description 21
- 235000019698 starch Nutrition 0.000 description 21
- 239000008107 starch Substances 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 235000013399 edible fruits Nutrition 0.000 description 17
- 235000013312 flour Nutrition 0.000 description 17
- 238000001816 cooling Methods 0.000 description 15
- 230000001804 emulsifying effect Effects 0.000 description 15
- 238000010025 steaming Methods 0.000 description 15
- 230000004438 eyesight Effects 0.000 description 14
- 235000012149 noodles Nutrition 0.000 description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 13
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 12
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 12
- 235000021552 granulated sugar Nutrition 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 229960003080 taurine Drugs 0.000 description 12
- 235000007516 Chrysanthemum Nutrition 0.000 description 11
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 11
- 244000037364 Cinnamomum aromaticum Species 0.000 description 11
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 11
- 240000000851 Vaccinium corymbosum Species 0.000 description 11
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 11
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 11
- 229930003268 Vitamin C Natural products 0.000 description 11
- 235000021014 blueberries Nutrition 0.000 description 11
- 239000003995 emulsifying agent Substances 0.000 description 11
- 229940087603 grape seed extract Drugs 0.000 description 11
- 235000002532 grape seed extract Nutrition 0.000 description 11
- 229920001542 oligosaccharide Polymers 0.000 description 11
- 150000002482 oligosaccharides Chemical class 0.000 description 11
- 239000003381 stabilizer Substances 0.000 description 11
- 235000019154 vitamin C Nutrition 0.000 description 11
- 239000011718 vitamin C Substances 0.000 description 11
- 239000001717 vitis vinifera seed extract Substances 0.000 description 11
- 238000010411 cooking Methods 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 238000007710 freezing Methods 0.000 description 10
- 230000008014 freezing Effects 0.000 description 10
- 150000004676 glycans Chemical class 0.000 description 10
- 238000000227 grinding Methods 0.000 description 10
- 229920001282 polysaccharide Polymers 0.000 description 10
- 239000005017 polysaccharide Substances 0.000 description 10
- 238000001694 spray drying Methods 0.000 description 10
- 238000010257 thawing Methods 0.000 description 10
- 238000009849 vacuum degassing Methods 0.000 description 10
- 235000013325 dietary fiber Nutrition 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 6
- 230000001902 propagating effect Effects 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 238000009777 vacuum freeze-drying Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000004267 EU approved acidity regulator Substances 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 238000000643 oven drying Methods 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 238000003892 spreading Methods 0.000 description 5
- 239000002002 slurry Substances 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229930190007 Baccatin Natural products 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/58—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a preparation method of medlar syrup, which is characterized in that fresh medlar and rehydrated medlar are pulped to obtain medlar pulp, enzymolysis is carried out, treated medlar pulp is obtained after subcritical liquid extraction, the medlar pulp is subjected to vacuum desolventizing and filtering to obtain medlar pulp residue and clear liquid, the clear liquid is concentrated, alcohol is added, the content of the alcohol is adjusted to be more than 80%, precipitate and clear liquid are separated, and the clear liquid is concentrated to obtain medlar syrup; or further separating and purifying the clear liquid after recovering alcohol to obtain fructus Lycii flavone and residual liquid, and concentrating the residual liquid to obtain fructus Lycii syrup; or treating the residue with ion exchange or macroporous resin to obtain permeate and eluate, and concentrating the permeate to obtain fructus Lycii syrup. The invention obtains the medlar syrup from the remainder of the extraction of the zeaxanthin dipalmitate, reduces the extraction cost of medlar functional substances, improves the utilization rate of medlar raw materials, completely extracts the raw materials, and improves the added value of the raw materials.
Description
The technical field is as follows:
the invention relates to a divisional application with the application number of 2017110746110 and the name of 'a method for extracting zeaxanthin dipalmitate from liquid medlar raw material', and the original application date is 2017-11-05.
The invention belongs to the field of biological extraction, and particularly relates to a preparation method of wolfberry syrup.
Technical background:
the medlar contains rich carotenoid, medlar flavone, medlar polysaccharide, betaine, monosaccharide, disaccharide, riboflavin, taurine, unsaturated fatty acid, eighteen amino acids and nineteen essential trace elements, wherein the carotenoid comprises zeaxanthin and esters thereof, baccatin, cryptoxanthin and β -carotene, and the zeaxanthin with the eyesight improving function is the highest of all fruits.
Regarding the deep processing and comprehensive utilization of medlar, the disclosed technology is 'supercritical medlar dregs extract and its production method' (CN100400133C), the technical proposal adopts the supercritical extraction technology, the main components of the extract are medlar seed oil, oleic acid, linoleic acid and other fatty acids account for more than 90% of the extract, the zeaxanthin only contains 0.6% -0.7%, the extraction cost is high, and the efficiency is low. The invention discloses a method for extracting zeaxanthin from medlar and medlar waste residue (CN103130698B), which is an invention patent with the publication date of 2016.03.16.A technical scheme is that medlar or medlar residue is separated into medlar seeds and medlar pulp, and the medlar seeds and the medlar pulp are respectively extracted to obtain a high-concentration zeaxanthin extract and high-purity medlar seeds. At present, no report of comprehensively extracting zeaxanthin dipalmitate, zeaxanthin, flavone, polysaccharide and betaine by directly taking fresh medlar or medlar juice and medlar pulp as raw materials is found, no report of separating dietary fiber and medlar protein from medlar is found, no report of preparing medlar syrup by medlar is found, and no report of processing residual saccharide by medlar to culture feed yeast is found. The existing extraction method has high production cost and low comprehensive utilization rate of the raw materials of the medlar.
The invention content is as follows:
the invention provides a method for extracting zeaxanthin dipalmitate from a liquid wolfberry raw material, which solves the technical problems of high extraction cost and low efficiency in the prior art, improves the extraction process of zeaxanthin dipalmitate, solves the technical problem of extraction by fresh wolfberry or liquid wolfberry and improves the comprehensive utilization rate of wolfberry.
In order to realize the purpose, the invention provides a method for extracting zeaxanthin dipalmitate, zeaxanthin, flavone, polysaccharide, dietary fiber and betaine from a liquid medlar raw material, and a preparation method of medlar syrup and medlar starch products, medlar eyesight improving beverage, medlar paste and medlar pills.
The steps for extracting zeaxanthin dipalmitate from liquid medlar raw material are as follows:
1) pretreating raw materials of medlar to obtain medlar pulp, and then adding pectinase and cellulase into the medlar pulp for enzymolysis;
further, the raw material pretreatment of the medlar refers to rehydration of dried medlar and rehydration of medlar residues, pulping and removing seeds to obtain medlar pulp;
further, the raw material pretreatment of the medlar refers to cleaning fresh medlar, pulping, removing seeds and concentrating to obtain medlar pulp;
further, the raw material pretreatment of the medlar refers to pulping fresh medlar, rehydrated medlar and rehydrated medlar residues to remove seeds to obtain medlar pulp, adding medlar powder accounting for 0-100% of the weight of the raw materials into the medlar pulp, and uniformly stirring to obtain medlar pulp;
furthermore, the added whole Chinese wolfberry powder is wall-broken Chinese wolfberry powder with the granularity of more than 300 meshes.
Furthermore, fresh medlar and a certain proportion of dry medlar are pulped together to obtain medlar pulp.
2) Adding the enzymolyzed fructus Lycii pulp into an extraction system, adding an extractant, and performing closed extraction under the extraction pressure of 0.4-0.5 Mpa, wherein the extraction system can be provided with reflux spray or stirring; recovering the extractant into an analysis tank when the balance is reached, decompressing to separate out the extract, recovering the extractant, collecting the zeaxanthin dipalmitate extract, and discharging the extracted Chinese wolfberry pulp from the bottom of the extraction tank after a plurality of stages of extraction.
Or performing multistage countercurrent extraction, adding the enzymolyzed fructus Lycii pulp into the first extraction tank of the multistage countercurrent extraction system, adding the extractant from the next stage (fresh extractant), performing closed extraction, stirring during extraction, or refluxing, maintaining the extraction pressure at 0.4-0.5 Mpa, recovering the extractant into the analysis tank when reaching balance, decompressing to separate out the extract, recovering the extractant, collecting zeaxanthin dipalmitate extract, introducing the pulp into the next stage extraction tank, adding the extractant from the next stage (fresh extractant), recovering the extractant containing the extract into the temporary storage tank when reaching balance, introducing the extractant into the first extraction tank for extraction, and introducing the pulp into the third stage extraction tank. After a plurality of stages of extraction, the extracted wolfberry pulp is discharged from the bottom of the last stage of extraction tank; the flow direction of the medlar pulp is opposite to that of the extracting agent, and the content of the zeaxanthin dipalmitate is gradually reduced from the entering of the extracting system to the discharging of the extracting system and is zero after a plurality of stages of extraction; the extractant is opposite, the content of the zeaxanthin dipalmitate in the extract is gradually increased after a plurality of stages of extraction until the zeaxanthin dipalmitate is highest after the first stage of extraction and is decompressed and separated out. The pressure of the extractant is kept between 0.4 and 0.5MPa when the extractant is conveyed into the extraction tank and extracted.
Further, the extractant is a subcritical fluid and is one of propane, butane, isobutane (R600a), 1, 1, 1, 2-tetrafluoroethane (R134a), dimethyl ether (DME), Liquefied Petroleum Gas (LPG) and sulfur hexafluoride.
Further, the extractant is recovered by a compressor.
Further, ethyl acetate which accounts for 0-10% of the weight of the raw materials is added when the fresh extracting agent is added.
3) Vacuum desolventizing the collected zeaxanthin dipalmitate extract until the residual amount of the extractant in the extract is lower than 8ppm, and collecting the zeaxanthin dipalmitate extract;
4) preparing the obtained zeaxanthin dipalmitate extract into zeaxanthin dipalmitate microcapsule powder with different contents;
a method for extracting zeaxanthin from fructus Lycii comprises saponifying zeaxanthin dipalmitate extract, separating, crystallizing, and drying to obtain pure zeaxanthin, and making the obtained pure zeaxanthin into microcapsule powder with different zeaxanthin contents.
The method for extracting the lycium chinense flavone from the liquid lycium chinense raw material mainly comprises rutin, chlorogenic acid and other components, and comprises the following steps:
1) and (3) performing vacuum desolventizing on the extracted wolfberry pulp collected in the method for extracting zeaxanthin dipalmitate from the liquid wolfberry raw material until the residual quantity of the extracting agent is lower than 8ppm, and collecting the wolfberry pulp for later use.
2) Filtering to obtain fructus Lycii pulp residue and clear liquid, and concentrating the clear liquid to obtain concentrated solution; the concentrated solution can be used as fructus Lycii syrup.
3) Adding alcohol into the concentrated solution, adjusting alcohol content to over 80%, standing, and separating out precipitate and clear solution;
4) recovering alcohol from the clear liquid, and further concentrating to obtain a second fructus Lycii syrup; recovering ethanol from the clear liquid, and further separating and purifying with nonpolar and low-polar macroporous resin to obtain fructus Lycii flavone and residual liquid; further concentrating the residue to obtain a third syrup.
A fructus Lycii dietary fiber is prepared by extracting flavone from liquid fructus Lycii material by step 1) to obtain fructus Lycii pulp residue, drying, and pulverizing.
A preparation method of lycium barbarum polysaccharide comprises the following steps:
1) method for extracting flavone from fructus Lycii, dissolving the precipitate obtained in step 2) with appropriate amount of water to make the concentration reach 10%;
2) adding 20% of chloroform and 4% of n-butanol into the solution, shaking vigorously for 30 minutes, centrifuging, recovering the lower layer of chloroform, pouring out the supernatant, recovering the n-butanol, washing the middle layer of denatured protein, and drying to obtain the lycium barbarum protein; the supernatant after n-butanol recovery is repeatedly subjected to the process until no denatured protein appears, and a supernatant is obtained;
3) concentrating the obtained supernatant, and vacuum freeze drying to obtain fructus Lycii polysaccharide.
A method for extracting fructus Lycii alkaloid comprises subjecting the residual liquid obtained in step 4) of extracting flavone from fructus Lycii to macroporous resin or ion exchange treatment to obtain permeate and eluate, desalting the eluate, concentrating, crystallizing, and drying to obtain fructus Lycii alkaloid; concentrating the permeate to obtain a fourth kind of fructus Lycii syrup.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight:
5-50% of medlar juice or fermented medlar juice, 5-10% of white granulated sugar, 0.01-1% of taurine, 0.1-5% of cassia seed extract, 0.1-5% of chrysanthemum extract, 1-5% of blueberry juice, 0.1-5% of grape seed extract, 0.01-1% of vitamin C, 0.1-1% of oligosaccharide, 0.001-0.1% of lutein, a plurality of arabinose, a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules, a plurality of sour agents, stabilizing agents and emulsifying agents, and the balance of water. Further, the addition amount of the arabinose is 3 to 5 percent of the white granulated sugar; further, the content ratio of zeaxanthin and lutein is 1: 5.
A wolfberry starch product contains 4-10% of wolfberry and one or two of zeaxanthin dipalmitate and zeaxanthin, and the addition amount of the wolfberry starch product is used for controlling the content (mass percentage) of the zeaxanthin in the wolfberry starch product to be 0-0.1%. Further, the medlar starch product comprises medlar vermicelli, medlar rice flour and medlar rice flour; further, the fructus Lycii refers to fructus Lycii powder, fructus Lycii juice, and fructus Lycii concentrated juice.
A fructus Lycii paste and fructus Lycii pill are prepared by collecting fructus Lycii pulp from extraction method of zeaxanthin dipalmitate in fructus Lycii, filtering to obtain fructus Lycii pulp residue and clear liquid, concentrating clear liquid to obtain concentrated solution, and further making the concentrated solution into fructus Lycii paste or fructus Lycii pill; or adding other Chinese medicinal extractive solution and adjuvants such as Mel into the concentrated solution, mixing, concentrating, and making into fructus Lycii paste or pill.
The other kind of wolfberry fruit paste and wolfberry fruit pill is prepared with the following steps:
1) filtering fructus Lycii pulp collected in the method for extracting zeaxanthin dipalmitate from fructus Lycii to obtain fructus Lycii pulp residue and clear liquid, and concentrating the clear liquid to obtain concentrated solution;
2) preparing a zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder collected in the extraction method of zeaxanthin dipalmitate in medlar into an emulsion;
3) adding other traditional Chinese medicine extracting solutions, honey and other auxiliary materials into the concentrated solution obtained in the step 1), uniformly mixing, continuously concentrating, adding the zeaxanthin dipalmitate or zeaxanthin emulsion obtained in the step 2) after the concentration is finished, and further preparing the lycium barbarum paste or the lycium barbarum pills.
A fructus Lycii feed yeast is prepared by adjusting components of the permeation solution obtained by extraction method of fructus Lycii alkaloid, inoculating yeast seed solution, fermenting, propagating, collecting cells, and drying.
The invention has the following beneficial effects:
1. the invention takes the medlar pulp prepared by rehydration of fresh medlar fruits or dry medlar fruits and medlar residues and medlar concentrated juice as raw materials, extracts zeaxanthin dipalmitate and zeaxanthin thereof from liquid raw materials, enlarges the raw material range of zeaxanthin extraction and reduces the extraction cost.
2. The fresh medlar and the dry medlar are used together, so that the concentration process is omitted, the energy is saved, the consumption is reduced, and the production cost is reduced.
3. The invention respectively obtains the medlar dietary fiber, medlar protein and medlar syrup from the remainder of the extraction of the zeaxanthin dipalmitate, extracts other medlar functional components such as medlar flavone, polysaccharide, alkaloid and the like, improves the utilization rate of medlar, and completely squeezes the raw materials.
4. The method is characterized in that fresh medlar, rehydrated medlar and rehydrated medlar residues are pulped to remove seeds to obtain medlar pulp, and a medlar raw material pretreatment scheme of medlar full powder with the weight of 0-100% of the raw material is added into the medlar pulp, so that the aim of medlar juice concentration is fulfilled, energy conservation and consumption reduction are realized, the extract contains a certain amount of fatty acid, and the collection of the zeaxanthin dipalmitate of the extract is more convenient.
5. The extraction agent adopts subcritical fluid, the extraction efficiency is high, the extraction agent is recovered by a compressor, and compared with the prior art, the energy consumption is saved.
6. The medlar extract is used to obtain medlar starch products, medlar eyesight improving beverage, medlar paste, medlar pills and other deep-processing products.
7. The four medlar syrups containing different functional substances are obtained at different stages of extraction.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
Example 1
The steps for extracting zeaxanthin dipalmitate from liquid medlar raw material are as follows:
1) pretreating fructus Lycii, adding 1-5 times of water into dried fructus Lycii or fructus Lycii residue, pulping, removing fructus Lycii seed to obtain fructus Lycii pulp, adding pectase and cellulase, performing enzymolysis, and homogenizing under high pressure.
2) Adding the enzymolyzed fructus Lycii pulp into an extraction system, adding an extractant, and performing closed extraction under the extraction pressure of 0.4-0.5 Mpa, wherein the extraction system can be provided with reflux spray or stirring; recovering the extractant into an analysis tank when the balance is reached, decompressing to separate out the extract, recovering the extractant, collecting the zeaxanthin dipalmitate extract, and discharging the extracted Chinese wolfberry pulp from the bottom of the extraction tank after a plurality of stages of extraction. The extractant used is one of propane, butane, isobutane (R600a), 1, 1, 1, 2-tetrafluoroethane (R134a), dimethyl ether (DME), Liquefied Petroleum Gas (LPG) and sulfur hexafluoride, and butane is used as the extractant in this example. The extractant is recovered by a compressor. To facilitate the collection of the extract, 0% by weight of ethyl acetate was added to the fresh extractant.
3) And (3) carrying out vacuum desolventizing on the collected zeaxanthin dipalmitate extract until the residual quantity of the extracting agent in the extract is lower than 8ppm, and collecting the zeaxanthin dipalmitate extract.
4) Dissolving the obtained zeaxanthin dipalmitate extract, emulsifying, selecting food gum as wall material, and spray drying to obtain zeaxanthin dipalmitate microcapsule powder with different contents.
Saponifying, separating, crystallizing, drying to obtain pure zeaxanthin, dissolving the obtained pure zeaxanthin, emulsifying, and spray drying with cellulose or food gelatin as wall material to obtain microcapsule powder with different zeaxanthin contents.
Filtering the medlar pulp discharged from the bottom of the extraction tank in the step 2) of extracting the zeaxanthin dipalmitate from the liquid medlar raw material to obtain medlar pulp residue and clear liquid, and drying and crushing the medlar pulp residue to obtain medlar dietary fiber; concentrating the clear liquid to obtain fructus Lycii syrup; adding alcohol into the concentrated solution, adjusting alcohol content to over 80%, standing, and separating out precipitate and clear solution; recovering alcohol from the clear liquid, and further concentrating to obtain a second fructus Lycii syrup; recovering ethanol from the clear liquid, and further separating and purifying with nonpolar and low-polar macroporous resin to obtain fructus Lycii flavone and residual liquid; further concentrating the residual liquid to obtain a third fructus Lycii syrup; and (3) treating the residual liquid by macroporous resin or ion exchange to obtain a permeate and an eluate, desalting, concentrating, crystallizing and drying the eluate to obtain the lycium barbarum alkaloid, and concentrating the permeate to obtain a fourth lycium barbarum syrup.
Dissolving the separated precipitate with appropriate amount of water to make the concentration reach 10%, adding 20% chloroform and 4% n-butanol, shaking vigorously for 30 min, centrifuging, recovering lower layer chloroform, decanting supernatant, recovering n-butanol, washing and drying middle layer denatured protein to obtain fructus Lycii protein; the supernatant after n-butanol recovery is repeatedly subjected to the process until no denatured protein appears, and a supernatant is obtained; concentrating the obtained supernatant, and vacuum freeze drying to obtain fructus Lycii polysaccharide.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 5% of medlar juice, 10% of white granulated sugar, 0.1% of taurine, 0.1% of cassia seed extract, 0.5% of chrysanthemum extract, 1.5% of blueberry juice, 0.15% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.0008% of lutein, 0.15% of arabinose, and a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules obtained by extraction, so that the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulators, stabilizers and emulsifiers, and the balance of water.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 5% of fermented medlar juice, 10% of white granulated sugar, 0.1% of taurine, 0.1% of cassia seed extract, 0.5% of chrysanthemum extract, 1.5% of blueberry juice, 0.15% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.0005% of lutein, 0.15% of arabinose, a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules, wherein the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulator, stabilizer and emulsifier, and the balance of water.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 8%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content of zeaxanthin (by mass) in fructus Lycii vermicelli at 0.0006%, pulverizing fructus Lycii into fructus Lycii powder of above 300 meshes, adding fructus Lycii powder and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 6%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0008%, soaking fructus Lycii, pulping, homogenizing to obtain fructus Lycii pulp of more than 300 meshes, adding fructus Lycii pulp and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting powder, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii rice flour contains fructus Lycii (dry basis) 4%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount of zeaxanthin in fructus Lycii rice flour is 0.0005%, and the fructus Lycii rice flour is prepared by adding rice, washed rice, soaked rice, starch and fructus Lycii juice, adding zeaxanthin dipalmitate, grinding, steaming, self-cooking, extruding, spreading, aging, steaming again, cooling, loosening, and oven drying.
A fructus Lycii rice noodle contains 10% of fructus Lycii (dry basis), one or two of zeaxanthin dipalmitate or zeaxanthin, and the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii rice noodle at 0.0008%, and the fructus Lycii rice noodle is prepared by fermenting rice, adding fructus Lycii, grinding into slurry, clarifying, filtering, steaming, extruding, and cooking.
A fructus Lycii paste and fructus Lycii pill are prepared by collecting fructus Lycii pulp from extraction method of zeaxanthin dipalmitate in fructus Lycii, filtering to obtain fructus Lycii pulp residue and clear liquid, concentrating clear liquid to obtain concentrated solution, and further making the concentrated solution into fructus Lycii paste or fructus Lycii pill; or adding other Chinese medicinal extractive solution and adjuvants such as Mel into the concentrated solution, mixing, concentrating, and making into fructus Lycii paste or pill; or adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder collected in the method for extracting zeaxanthin dipalmitate from fructus Lycii into the concentrated solution, or emulsifying liquid prepared from zeaxanthin microcapsules, and further making into fructus Lycii paste and fructus Lycii pill; or adding other Chinese medicinal extractive solution and Mel into the concentrated solution, mixing, concentrating, adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder or zeaxanthin microcapsule emulsion, and making into fructus Lycii paste and fructus Lycii pill.
A fructus Lycii feed yeast is prepared by adjusting components of the permeation solution obtained by extraction method of fructus Lycii alkaloid, inoculating yeast seed solution, fermenting, propagating, collecting cells, and drying.
Example 2
The steps for extracting zeaxanthin dipalmitate from liquid medlar raw material are as follows:
2) pretreating fructus Lycii, adding 1-5 times of water into dried fructus Lycii or fructus Lycii residue, pulping, removing fructus Lycii seed to obtain fructus Lycii pulp, adding pectase and cellulase, performing enzymolysis, and homogenizing under high pressure.
2) Adding the enzymolyzed wolfberry fruit pulp into a first extraction tank of a multistage countercurrent extraction system, adding an extracting agent from the next stage (fresh extracting agent), starting reflux and stirring for closed extraction, keeping the extraction pressure at 0.4-0.5 Mpa, recovering the extracting agent into an analysis tank when the balance is achieved, decompressing to separate out the extract, recovering the extracting agent, collecting the zeaxanthin dipalmitate extract, adding the fruit pulp into the next stage extraction tank, adding the extracting agent from the next stage (fresh extracting agent) for extraction, recovering the extracting agent containing the extract into a temporary storage tank when the balance is achieved, introducing the temporary storage tank into the first extraction tank for extraction, and introducing the fruit pulp into a third stage extraction tank. After a plurality of stages of extraction, the extracted wolfberry pulp is discharged from the bottom of the last stage of extraction tank; the flow direction of the medlar pulp is opposite to that of the extracting agent, and the content of the zeaxanthin dipalmitate is gradually reduced from the entering of the extracting system to the discharging of the extracting system and is zero after a plurality of stages of extraction; the extractant is opposite, the content of the zeaxanthin dipalmitate in the extract is gradually increased after a plurality of stages of extraction until the zeaxanthin dipalmitate is highest after the first stage of extraction and is decompressed and separated out. The pressure of the extractant is kept between 0.4 and 0.5MPa when the extractant is conveyed into the extraction tank and extracted. The extractant used is one of propane, butane, isobutane (R600a), 1, 1, 1, 2-tetrafluoroethane (R134a), dimethyl ether (DME), Liquefied Petroleum Gas (LPG) and sulfur hexafluoride, and butane is used as the extractant in this example. The extractant is recovered by a compressor. To facilitate the collection of the extract, 0% by weight of ethyl acetate was added to the fresh extractant.
3) And (3) carrying out vacuum desolventizing on the collected zeaxanthin dipalmitate extract until the residual quantity of the extracting agent in the extract is lower than 8ppm, and collecting the zeaxanthin dipalmitate extract.
4) Dissolving the obtained zeaxanthin dipalmitate extract, emulsifying, selecting food gum as wall material, and spray drying to obtain zeaxanthin dipalmitate microcapsule powder with different contents.
Saponifying, separating, crystallizing, drying to obtain pure zeaxanthin, dissolving the obtained pure zeaxanthin, emulsifying, and spray drying with cellulose or food gelatin as wall material to obtain microcapsule powder with different zeaxanthin contents.
Filtering the medlar pulp discharged from the bottom of the last-stage extraction tank in the step 2) of extracting the zeaxanthin dipalmitate from the liquid medlar raw material to obtain medlar pulp residue and clear liquid, and drying and crushing the medlar pulp residue to obtain medlar dietary fiber; concentrating the clear liquid to obtain fructus Lycii syrup; adding alcohol into the concentrated solution, adjusting alcohol content to over 80%, standing, and separating out precipitate and clear solution; recovering alcohol from the clear liquid, and further concentrating to obtain a second fructus Lycii syrup; recovering ethanol from the clear liquid, and further separating and purifying with nonpolar and low-polar macroporous resin to obtain fructus Lycii flavone and residual liquid; further concentrating the residual liquid to obtain a third fructus Lycii syrup; and (3) treating the residual liquid by macroporous resin or ion exchange to obtain a permeate and an eluate, desalting, concentrating, crystallizing and drying the eluate to obtain the lycium barbarum alkaloid, and concentrating the permeate to obtain a fourth lycium barbarum syrup.
Dissolving the separated precipitate with appropriate amount of water to make the concentration reach 10%, adding 20% chloroform and 4% n-butanol, shaking vigorously for 30 min, centrifuging, recovering lower layer chloroform, decanting supernatant, recovering n-butanol, washing and drying middle layer denatured protein to obtain fructus Lycii protein; the supernatant after n-butanol recovery is repeatedly subjected to the process until no denatured protein appears, and a supernatant is obtained; concentrating the obtained supernatant, and vacuum freeze drying to obtain fructus Lycii polysaccharide.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 5% of medlar juice, 10% of white granulated sugar, 0.1% of taurine, 0.1% of cassia seed extract, 0.5% of chrysanthemum extract, 1.5% of blueberry juice, 0.15% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.0008% of lutein, 0.15% of arabinose, and a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules obtained by extraction, so that the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulators, stabilizers and emulsifiers, and the balance of water.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 5% of fermented medlar juice, 10% of white granulated sugar, 0.1% of taurine, 0.1% of cassia seed extract, 0.5% of chrysanthemum extract, 1.5% of blueberry juice, 0.15% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.0005% of lutein, 0.15% of arabinose, a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules, wherein the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulator, stabilizer and emulsifier, and the balance of water.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 8%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content of zeaxanthin (by mass) in fructus Lycii vermicelli at 0.0006%, pulverizing fructus Lycii into fructus Lycii powder of above 300 meshes, adding fructus Lycii powder and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 6%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0008%, soaking fructus Lycii, pulping, homogenizing to obtain fructus Lycii pulp of more than 300 meshes, adding fructus Lycii pulp and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting powder, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii rice flour contains fructus Lycii (dry basis) 4%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount of zeaxanthin in fructus Lycii rice flour is 0.0005%, and the fructus Lycii rice flour is prepared by adding rice, washed rice, soaked rice, starch and fructus Lycii juice, adding zeaxanthin dipalmitate, grinding, steaming, self-cooking, extruding, spreading, aging, steaming again, cooling, loosening, and oven drying.
A fructus Lycii rice noodle contains 10% of fructus Lycii (dry basis), one or two of zeaxanthin dipalmitate or zeaxanthin, and the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii rice noodle at 0.0008%, and the fructus Lycii rice noodle is prepared by fermenting rice, adding fructus Lycii, grinding into slurry, clarifying, filtering, steaming, extruding, and cooking.
A fructus Lycii paste and fructus Lycii pill are prepared by collecting fructus Lycii pulp from extraction method of zeaxanthin dipalmitate in fructus Lycii, filtering to obtain fructus Lycii pulp residue and clear liquid, concentrating clear liquid to obtain concentrated solution, and further making the concentrated solution into fructus Lycii paste or fructus Lycii pill; or adding other Chinese medicinal extractive solution and adjuvants such as Mel into the concentrated solution, mixing, concentrating, and making into fructus Lycii paste or pill; or adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder collected in the method for extracting zeaxanthin dipalmitate from fructus Lycii into the concentrated solution, or emulsifying liquid prepared from zeaxanthin microcapsules, and further making into fructus Lycii paste and fructus Lycii pill; or adding other Chinese medicinal extractive solution and Mel into the concentrated solution, mixing, concentrating, adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder or zeaxanthin microcapsule emulsion, and making into fructus Lycii paste and fructus Lycii pill.
A fructus Lycii feed yeast is prepared by adjusting components of the permeation solution obtained by extraction method of fructus Lycii alkaloid, inoculating yeast seed solution, fermenting, propagating, collecting cells, and drying.
Example 3
The steps for extracting zeaxanthin dipalmitate from liquid medlar raw material are as follows:
1) pretreating fructus Lycii, cleaning fresh fructus Lycii, pulping to remove fructus Lycii seeds, concentrating to obtain fructus Lycii pulp, adding pectase and cellulase for enzymolysis, and homogenizing under high pressure.
2) Adding the enzymolyzed wolfberry fruit pulp into a first extraction tank of a multistage countercurrent extraction system, adding an extracting agent from the next stage (fresh extracting agent), starting reflux and stirring for closed extraction, keeping the extraction pressure at 0.4-0.5 Mpa, recovering the extracting agent into an analysis tank when the balance is achieved, decompressing to separate out the extract, recovering the extracting agent, collecting the zeaxanthin dipalmitate extract, adding the fruit pulp into the next stage extraction tank, adding the extracting agent from the next stage (fresh extracting agent) for extraction, recovering the extracting agent containing the extract into a temporary storage tank when the balance is achieved, introducing the temporary storage tank into the first extraction tank for extraction, and introducing the fruit pulp into a third stage extraction tank. After a plurality of stages of extraction, the extracted wolfberry pulp is discharged from the bottom of the last stage of extraction tank; the flow direction of the medlar pulp is opposite to that of the extracting agent, and the content of the zeaxanthin dipalmitate is gradually reduced from the entering of the extracting system to the discharging of the extracting system and is zero after a plurality of stages of extraction; the extractant is opposite, the content of the zeaxanthin dipalmitate in the extract is gradually increased after a plurality of stages of extraction until the zeaxanthin dipalmitate is highest after the first stage of extraction and is decompressed and separated out. The pressure of the extractant is kept between 0.4 and 0.5MPa when the extractant is conveyed into the extraction tank and extracted. The extractant used is one of propane, butane, isobutane (R600a), 1, 1, 1, 2-tetrafluoroethane (R134a), dimethyl ether (DME), Liquefied Petroleum Gas (LPG) and sulfur hexafluoride, and butane is used as the extractant in this example. The extractant is recovered by a compressor. To facilitate the collection of the extract, 10% by weight of ethyl acetate was added to the fresh extractant.
3) And (3) carrying out vacuum desolventizing on the collected zeaxanthin dipalmitate extract until the residual quantity of the extracting agent in the extract is lower than 8ppm, and collecting the zeaxanthin dipalmitate extract.
4) Dissolving the obtained zeaxanthin dipalmitate extract, emulsifying, selecting food gum as wall material, and spray drying to obtain zeaxanthin dipalmitate microcapsule powder with different contents.
Saponifying, separating, crystallizing, drying to obtain pure zeaxanthin, dissolving the obtained pure zeaxanthin, emulsifying, and spray drying with cellulose or food gelatin as wall material to obtain microcapsule powder with different zeaxanthin contents.
Filtering the medlar pulp discharged from the bottom of the last-stage extraction tank in the step 2) of extracting the zeaxanthin dipalmitate from the liquid medlar raw material to obtain medlar pulp residue and clear liquid, and drying and crushing the medlar pulp residue to obtain medlar dietary fiber; concentrating the clear liquid to obtain fructus Lycii syrup; adding alcohol into the concentrated solution, adjusting alcohol content to over 80%, standing, and separating out precipitate and clear solution; recovering alcohol from the clear liquid, and further concentrating to obtain a second fructus Lycii syrup; recovering ethanol from the clear liquid, and further separating and purifying with nonpolar and low-polar macroporous resin to obtain fructus Lycii flavone and residual liquid; further concentrating the residual liquid to obtain a third fructus Lycii syrup; and (3) treating the residual liquid by macroporous resin or ion exchange to obtain a permeate and an eluate, desalting, concentrating, crystallizing and drying the eluate to obtain the lycium barbarum alkaloid, and concentrating the permeate to obtain a fourth lycium barbarum syrup.
Dissolving the separated precipitate with appropriate amount of water to make the concentration reach 10%, adding 20% chloroform and 4% n-butanol, shaking vigorously for 30 min, centrifuging, recovering lower layer chloroform, decanting supernatant, recovering n-butanol, washing and drying middle layer denatured protein to obtain fructus Lycii protein; the supernatant after n-butanol recovery is repeatedly subjected to the process until no denatured protein appears, and a supernatant is obtained; concentrating the obtained supernatant, and vacuum freeze drying to obtain fructus Lycii polysaccharide.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 10% of medlar juice, 8% of white granulated sugar, 0.1% of taurine, 0.2% of cassia seed extract, 0.5% of chrysanthemum extract, 0.5% of blueberry juice, 0.15% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.0009% of lutein, 0.15% of arabinose, and a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules obtained by extraction, so that the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulators, stabilizers and emulsifiers, and the balance of water.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 10% of fermented medlar juice, 10% of white granulated sugar, 0.15% of taurine, 0.21% of cassia seed extract, 0.5% of chrysanthemum extract, 0.5% of blueberry juice, 0.45% of grape seed extract, 0.02% of vitamin C, 0.11% of oligosaccharide, 0.0006% of lutein, 0.15% of arabinose, a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules, wherein the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulator, stabilizer and emulsifier, and the balance of water.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 8%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0001%, pulverizing fructus Lycii into fructus Lycii powder of above 300 meshes, adding fructus Lycii powder and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 6%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0008%, soaking fructus Lycii, pulping, homogenizing to obtain fructus Lycii pulp of more than 300 meshes, adding fructus Lycii pulp and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting powder, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii rice flour contains fructus Lycii (dry basis) 5%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount of zeaxanthin in fructus Lycii rice flour is 0.0006%, rice, washed rice, soaked rice, starch and fructus Lycii juice are added, and zeaxanthin dipalmitate is added, and the fructus Lycii rice flour is prepared by grinding, steaming, self-cooking, extruding, spreading, aging, steaming again, cooling, loosening, and oven drying.
A fructus Lycii rice noodle contains 10% of fructus Lycii (dry basis), one or two of zeaxanthin dipalmitate or zeaxanthin, and the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii rice noodle at 0.0008%, and the fructus Lycii rice noodle is prepared by fermenting rice, adding fructus Lycii, grinding into slurry, clarifying, filtering, steaming, extruding, and cooking.
A fructus Lycii paste and fructus Lycii pill are prepared by collecting fructus Lycii pulp from extraction method of zeaxanthin dipalmitate in fructus Lycii, filtering to obtain fructus Lycii pulp residue and clear liquid, concentrating clear liquid to obtain concentrated solution, and further making the concentrated solution into fructus Lycii paste or fructus Lycii pill; or adding other Chinese medicinal extractive solution and adjuvants such as Mel into the concentrated solution, mixing, concentrating, and making into fructus Lycii paste or pill; or adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder collected in the method for extracting zeaxanthin dipalmitate from fructus Lycii into the concentrated solution, or emulsifying liquid prepared from zeaxanthin microcapsules, and further making into fructus Lycii paste and fructus Lycii pill; or adding other Chinese medicinal extractive solution and Mel into the concentrated solution, mixing, concentrating, adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder or zeaxanthin microcapsule emulsion, and making into fructus Lycii paste and fructus Lycii pill.
A fructus Lycii feed yeast is prepared by adjusting components of the permeation solution obtained by extraction method of fructus Lycii alkaloid, inoculating yeast seed solution, fermenting, propagating, collecting cells, and drying.
Example 4
The steps for extracting zeaxanthin dipalmitate from liquid medlar raw material are as follows:
1) pretreating raw materials of medlar, pulping fresh medlar, rehydrated medlar and rehydrated medlar residues, removing seeds to obtain medlar pulp, adding whole medlar powder accounting for 0-100% of the weight of the raw materials, stirring and dissolving to obtain medlar pulp, adding pectinase and cellulase for enzymolysis, and then homogenizing under high pressure, wherein the whole medlar powder is wall-broken medlar powder with the granularity of more than 300 meshes.
2) Adding the enzymolyzed wolfberry fruit pulp into a first extraction tank of a multistage countercurrent extraction system, adding an extracting agent from the next stage (fresh extracting agent), starting reflux and stirring for closed extraction, keeping the extraction pressure at 0.4-0.5 Mpa, recovering the extracting agent into an analysis tank when the balance is achieved, decompressing to separate out the extract, recovering the extracting agent, collecting the zeaxanthin dipalmitate extract, adding the fruit pulp into the next stage extraction tank, adding the extracting agent from the next stage (fresh extracting agent) for extraction, recovering the extracting agent containing the extract into a temporary storage tank when the balance is achieved, introducing the temporary storage tank into the first extraction tank for extraction, and introducing the fruit pulp into a third stage extraction tank. After a plurality of stages of extraction, the extracted wolfberry pulp is discharged from the bottom of the last stage of extraction tank; the flow direction of the medlar pulp is opposite to that of the extracting agent, and the content of the zeaxanthin dipalmitate is gradually reduced from the entering of the extracting system to the discharging of the extracting system and is zero after a plurality of stages of extraction; the extractant is opposite, the content of the zeaxanthin dipalmitate in the extract is gradually increased after a plurality of stages of extraction until the zeaxanthin dipalmitate is highest after the first stage of extraction and is decompressed and separated out. The pressure of the extractant is kept between 0.4 and 0.5MPa when the extractant is conveyed into the extraction tank and extracted. The extractant used is one of propane, butane, isobutane (R600a), 1, 1, 1, 2-tetrafluoroethane (R134a), dimethyl ether (DME), Liquefied Petroleum Gas (LPG) and sulfur hexafluoride, and butane is used as the extractant in this example. The extractant is recovered by a compressor. To facilitate the collection of the extract, 5% by weight of ethyl acetate was added to the fresh extractant.
3) And (3) carrying out vacuum desolventizing on the collected zeaxanthin dipalmitate extract until the residual quantity of the extracting agent in the extract is lower than 8ppm, and collecting the zeaxanthin dipalmitate extract.
4) Dissolving the obtained zeaxanthin dipalmitate extract, emulsifying, selecting food gum as wall material, and spray drying to obtain zeaxanthin dipalmitate microcapsule powder with different contents.
Saponifying, separating, crystallizing, drying to obtain pure zeaxanthin, dissolving the obtained pure zeaxanthin, emulsifying, and spray drying with cellulose or food gelatin as wall material to obtain microcapsule powder with different zeaxanthin contents.
Filtering the medlar pulp discharged from the bottom of the last-stage extraction tank in the step 2) of extracting the zeaxanthin dipalmitate from the liquid medlar raw material to obtain medlar pulp residue and clear liquid, and drying and crushing the medlar pulp residue to obtain medlar dietary fiber; concentrating the clear liquid to obtain fructus Lycii syrup; adding alcohol into the concentrated solution, adjusting alcohol content to over 80%, standing, and separating out precipitate and clear solution; recovering alcohol from the clear liquid, and further concentrating to obtain a second fructus Lycii syrup; recovering ethanol from the clear liquid, and further separating and purifying with nonpolar and low-polar macroporous resin to obtain fructus Lycii flavone and residual liquid; further concentrating the residual liquid to obtain a third fructus Lycii syrup; and (3) treating the residual liquid by macroporous resin or ion exchange to obtain a permeate and an eluate, desalting, concentrating, crystallizing and drying the eluate to obtain the lycium barbarum alkaloid, and concentrating the permeate to obtain a fourth lycium barbarum syrup.
Dissolving the separated precipitate with appropriate amount of water to make the concentration reach 10%, adding 20% chloroform and 4% n-butanol, shaking vigorously for 30 min, centrifuging, recovering lower layer chloroform, decanting supernatant, recovering n-butanol, washing and drying middle layer denatured protein to obtain fructus Lycii protein; the supernatant after n-butanol recovery is repeatedly subjected to the process until no denatured protein appears, and a supernatant is obtained; concentrating the obtained supernatant, and vacuum freeze drying to obtain fructus Lycii polysaccharide.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 20% of medlar juice, 7% of white granulated sugar, 0.15% of taurine, 0.3% of cassia seed extract, 0.25% of chrysanthemum extract, 1.5% of blueberry juice, 0.25% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.005% of lutein, 0.15% of arabinose, and a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules obtained by extraction, so that the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulators, stabilizers and emulsifiers, and the balance of water.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 25% of fermented wolfberry juice, 8% of white granulated sugar, 0.21% of taurine, 0.31% of cassia seed extract, 0.45% of chrysanthemum extract, 1.25% of blueberry juice, 0.25% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.0005% of lutein, 0.15% of arabinose, a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules, wherein the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulator, stabilizer and emulsifier, and the balance of water.
A fructus Lycii vermicelli comprises 10% of fructus Lycii (dry basis), and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0009%, pulverizing fructus Lycii into fructus Lycii powder of above 300 meshes, adding fructus Lycii powder and zeaxanthin dipalmitate into starch, mixing, adding water, pasting, mixing, vacuum degassing, leaking powder, decocting, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 6%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0008%, soaking fructus Lycii, pulping, homogenizing to obtain fructus Lycii pulp of more than 300 meshes, adding fructus Lycii pulp and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting powder, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii rice flour contains fructus Lycii (dry basis) 5%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount of zeaxanthin in fructus Lycii rice flour is 0.0005%, and the fructus Lycii rice flour is prepared by adding rice, washed rice, soaked rice, starch and fructus Lycii juice, adding zeaxanthin dipalmitate, grinding, steaming, self-cooking, extruding, spreading, aging, steaming again, cooling, loosening, and oven drying.
A rice noodle containing fructus Lycii is prepared from fructus Lycii (dry basis) 5%, zeaxanthin dipalmitate or zeaxanthin, by controlling the zeaxanthin content (by mass) in the rice noodle at 0.004%, fermenting rice, adding fructus Lycii, grinding, filtering, steaming, extruding, and cooking.
A fructus Lycii paste and fructus Lycii pill are prepared by collecting fructus Lycii pulp from extraction method of zeaxanthin dipalmitate in fructus Lycii, filtering to obtain fructus Lycii pulp residue and clear liquid, concentrating clear liquid to obtain concentrated solution, and further making the concentrated solution into fructus Lycii paste or fructus Lycii pill; or adding other Chinese medicinal extractive solution and adjuvants such as Mel into the concentrated solution, mixing, concentrating, and making into fructus Lycii paste or pill; or adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder collected in the method for extracting zeaxanthin dipalmitate from fructus Lycii into the concentrated solution, or emulsifying liquid prepared from zeaxanthin microcapsules, and further making into fructus Lycii paste and fructus Lycii pill; or adding other Chinese medicinal extractive solution and Mel into the concentrated solution, mixing, concentrating, adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder or zeaxanthin microcapsule emulsion, and making into fructus Lycii paste and fructus Lycii pill.
A fructus Lycii feed yeast is prepared by adjusting components of the permeation solution obtained by extraction method of fructus Lycii alkaloid, inoculating yeast seed solution, fermenting, propagating, collecting cells, and drying.
Example 5
The steps for extracting zeaxanthin dipalmitate from liquid medlar raw material are as follows:
1) pretreating fructus Lycii, pulping fresh fructus Lycii and dry fructus Lycii at a ratio of 1:1 to obtain fructus Lycii pulp, adding pectase and cellulase into the fructus Lycii pulp for enzymolysis, and homogenizing under high pressure.
2) Adding the enzymolyzed wolfberry fruit pulp into a first extraction tank of a multistage countercurrent extraction system, adding an extracting agent from the next stage (fresh extracting agent), starting reflux and stirring for closed extraction, keeping the extraction pressure at 0.4-0.5 Mpa, recovering the extracting agent into an analysis tank when the balance is achieved, decompressing to separate out the extract, recovering the extracting agent, collecting the zeaxanthin dipalmitate extract, adding the fruit pulp into the next stage extraction tank, adding the extracting agent from the next stage (fresh extracting agent) for extraction, recovering the extracting agent containing the extract into a temporary storage tank when the balance is achieved, introducing the temporary storage tank into the first extraction tank for extraction, and introducing the fruit pulp into a third stage extraction tank. After a plurality of stages of extraction, the extracted wolfberry pulp is discharged from the bottom of the last stage of extraction tank; the flow direction of the medlar pulp is opposite to that of the extracting agent, and the content of the zeaxanthin dipalmitate is gradually reduced from the entering of the extracting system to the discharging of the extracting system and is zero after a plurality of stages of extraction; the extractant is opposite, the content of the zeaxanthin dipalmitate in the extract is gradually increased after a plurality of stages of extraction until the zeaxanthin dipalmitate is highest after the first stage of extraction and is decompressed and separated out. The pressure of the extractant is kept between 0.4 and 0.5MPa when the extractant is conveyed into the extraction tank and extracted. The extractant used is one of propane, butane, isobutane (R600a), 1, 1, 1, 2-tetrafluoroethane (R134a), dimethyl ether (DME), Liquefied Petroleum Gas (LPG) and sulfur hexafluoride, and butane is used as the extractant in this example. The extractant is recovered by a compressor. To facilitate the collection of the extract, ethyl acetate, 7% of the weight of the starting material, was added while adding fresh extractant.
3) And (3) carrying out vacuum desolventizing on the collected zeaxanthin dipalmitate extract until the residual quantity of the extracting agent in the extract is lower than 8ppm, and collecting the zeaxanthin dipalmitate extract.
4) Dissolving the obtained zeaxanthin dipalmitate extract, emulsifying, selecting food gum as wall material, and spray drying to obtain zeaxanthin dipalmitate microcapsule powder with different contents.
Saponifying, separating, crystallizing, drying to obtain pure zeaxanthin, dissolving the obtained pure zeaxanthin, emulsifying, and spray drying with cellulose or food gelatin as wall material to obtain microcapsule powder with different zeaxanthin contents.
Filtering the medlar pulp discharged from the bottom of the last-stage extraction tank in the step 2) of extracting the zeaxanthin dipalmitate from the liquid medlar raw material to obtain medlar pulp residue and clear liquid, and drying and crushing the medlar pulp residue to obtain medlar dietary fiber; concentrating the clear liquid to obtain fructus Lycii syrup; adding alcohol into the concentrated solution, adjusting alcohol content to over 80%, standing, and separating out precipitate and clear solution; recovering alcohol from the clear liquid, and further concentrating to obtain a second fructus Lycii syrup; recovering ethanol from the clear liquid, and further separating and purifying with nonpolar and low-polar macroporous resin to obtain fructus Lycii flavone and residual liquid; further concentrating the residual liquid to obtain a third fructus Lycii syrup; and (3) treating the residual liquid by macroporous resin or ion exchange to obtain a permeate and an eluate, desalting, concentrating, crystallizing and drying the eluate to obtain the lycium barbarum alkaloid, and concentrating the permeate to obtain a fourth lycium barbarum syrup.
Dissolving the separated precipitate with appropriate amount of water to make the concentration reach 10%, adding 20% chloroform and 4% n-butanol, shaking vigorously for 30 min, centrifuging, recovering lower layer chloroform, decanting supernatant, recovering n-butanol, washing and drying middle layer denatured protein to obtain fructus Lycii protein; the supernatant after n-butanol recovery is repeatedly subjected to the process until no denatured protein appears, and a supernatant is obtained; concentrating the obtained supernatant, and vacuum freeze drying to obtain fructus Lycii polysaccharide.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 50% of medlar juice, 2% of white granulated sugar, 0.1% of taurine, 0.1% of cassia seed extract, 0.5% of chrysanthemum extract, 1.5% of blueberry juice, 0.15% of grape seed extract, 0.01% of vitamin C, 0.11% of oligosaccharide, 0.005% of lutein, 0.15% of arabinose, and a plurality of extracted zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules, so that the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulators, stabilizers and emulsifiers, and the balance of water.
An eyesight improving medlar beverage containing zeaxanthin, which is characterized by comprising the following components in percentage by weight: 50% of fermented wolfberry juice, 5% of white granulated sugar, 0.21% of taurine, 0.3% of cassia seed extract, 0.25% of chrysanthemum extract, 0.5% of blueberry juice, 0.85% of grape seed extract, 0.01% of vitamin C, 0.21% of oligosaccharide, 0.005% of lutein, 0.15% of arabinose, a plurality of zeaxanthin dipalmitate microcapsules or zeaxanthin microcapsules, wherein the content ratio of zeaxanthin to lutein in the beverage is 1:5, a plurality of acidity regulator, stabilizer and emulsifier, and the balance of water.
A fructus Lycii vermicelli comprises 10% of fructus Lycii (dry basis), and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0009%, pulverizing fructus Lycii into fructus Lycii powder of above 300 meshes, adding fructus Lycii powder and zeaxanthin dipalmitate into starch, mixing, adding water, pasting, mixing, vacuum degassing, leaking powder, decocting, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii vermicelli comprises fructus Lycii (dry basis) 6%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii vermicelli at 0.0008%, soaking fructus Lycii, pulping, homogenizing to obtain fructus Lycii pulp of more than 300 meshes, adding fructus Lycii pulp and zeaxanthin dipalmitate into starch, mixing, adding water, pulping, mixing, vacuum degassing, leaking powder, decocting powder, cooling, freezing, thawing, and drying to obtain fructus Lycii vermicelli.
A fructus Lycii rice flour contains fructus Lycii (dry basis) 4%, and one or two of zeaxanthin dipalmitate or zeaxanthin, wherein the addition amount of zeaxanthin in fructus Lycii rice flour is 0.0005%, and the fructus Lycii rice flour is prepared by adding rice, washed rice, soaked rice, starch and fructus Lycii juice, adding zeaxanthin dipalmitate, grinding, steaming, self-cooking, extruding, spreading, aging, steaming again, cooling, loosening, and oven drying.
A fructus Lycii rice noodle contains fructus Lycii (dry basis) 3%, and one or two of zeaxanthin dipalmitate or zeaxanthin, the addition amount is controlled to control the content (mass percentage) of zeaxanthin in the fructus Lycii rice noodle at 0.0004%, and the fructus Lycii rice noodle is prepared by fermenting rice, adding fructus Lycii, grinding into slurry, clarifying, filtering, steaming, extruding, and cooking.
A fructus Lycii paste and fructus Lycii pill are prepared by collecting fructus Lycii pulp from extraction method of zeaxanthin dipalmitate in fructus Lycii, filtering to obtain fructus Lycii pulp residue and clear liquid, concentrating clear liquid to obtain concentrated solution, and further making the concentrated solution into fructus Lycii paste or fructus Lycii pill; or adding other Chinese medicinal extractive solution and adjuvants such as Mel into the concentrated solution, mixing, concentrating, and making into fructus Lycii paste or pill; or adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder collected in the method for extracting zeaxanthin dipalmitate from fructus Lycii into the concentrated solution, or emulsifying liquid prepared from zeaxanthin microcapsules, and further making into fructus Lycii paste and fructus Lycii pill; or adding other Chinese medicinal extractive solution and Mel into the concentrated solution, mixing, concentrating, adding zeaxanthin dipalmitate extract or zeaxanthin dipalmitate microcapsule powder or zeaxanthin microcapsule emulsion, and making into fructus Lycii paste and fructus Lycii pill.
A fructus Lycii feed yeast is prepared by adjusting components of the permeation solution obtained by extraction method of fructus Lycii alkaloid, inoculating yeast seed solution, fermenting, propagating, collecting cells, and drying.
The present invention is not limited to the above-described embodiments.
Although the foregoing examples describe specific embodiments of the present invention, those skilled in the art will recognize that many changes and modifications may be made thereto without departing from the spirit and scope of the invention, the results of which are within the scope of the invention.
Claims (1)
1. A method for preparing a Chinese wolfberry syrup, comprising the steps of:
1) pre-treating fructus Lycii raw material, including rehydration of dried fructus Lycii, rehydration of fructus Lycii residue, pulping, and removing seeds to obtain fructus Lycii pulp; cleaning fresh fructus Lycii, pulping, and removing seeds to obtain fructus Lycii pulp; pulping fresh fructus Lycii, rehydrated fructus Lycii, and rehydrated fructus Lycii residue, removing seeds to obtain fructus Lycii pulp, adding fructus Lycii powder 0-100% of the weight of the raw materials into the fructus Lycii pulp, and stirring to obtain fructus Lycii pulp; pulping fresh fructus Lycii and dried fructus Lycii at a certain ratio to obtain fructus Lycii pulp; dissolving the whole Chinese wolfberry powder to obtain Chinese wolfberry pulp; adding pectinase and cellulase into the obtained fructus Lycii pulp for enzymolysis;
2) adding the enzymatic fructus Lycii pulp into an extraction system, adding an extractant, performing closed extraction under the extraction pressure of 0.1-10 Mpa, recovering the extractant into an analysis tank when the balance is reached, decompressing to separate out the extract, recovering the extractant, collecting zeaxanthin dipalmitate extract, and discharging the extracted fructus Lycii pulp from the bottom of the extraction tank after several stages of extraction; the extractant is recovered by a compressor; the extractant is one of propane, butane, isobutane (R600a), 1, 1, 1, 2-tetrafluoroethane (R134a), dimethyl ether (DME), Liquefied Petroleum Gas (LPG), carbon dioxide and sulfur hexafluoride;
3) vacuum desolventizing the collected zeaxanthin dipalmitate extract until the residual quantity of the extract extractant is lower than 8ppm, and collecting the zeaxanthin dipalmitate extract;
4) preparing the obtained zeaxanthin dipalmitate extract into zeaxanthin dipalmitate microcapsule powder with different contents;
5) step 2) carrying out vacuum desolventizing on the medlar pulp discharged from the bottom of the last-stage extraction tank after extraction is finished until the residual quantity of the extracting agent is lower than 8ppm, and collecting the medlar pulp for later use;
6) filtering the collected medlar pulp to obtain medlar pulp residue and clear liquid, and concentrating the clear liquid to obtain concentrated solution;
7) adding alcohol into the concentrated solution, adjusting alcohol content to over 80%, standing, and separating out precipitate and clear solution;
8) recovering alcohol from the clear liquid, further separating and purifying to obtain medlar flavone and residual liquid;
9) treating the residual liquid obtained in the step 8) by ion exchange or macroporous resin to obtain a permeate and an eluent, desalting, concentrating, crystallizing and drying the eluent to obtain the lycium barbarum alkaloid;
10) the medlar syrup is obtained by concentrating the clear liquid obtained in the step 7) after recovering alcohol; the medlar syrup is formed by concentrating the residual liquid obtained in the step 8); the medlar syrup is obtained by concentrating the permeate liquid obtained in the step 9).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911210590.XA CN110892987A (en) | 2017-11-05 | 2017-11-05 | Preparation method of wolfberry syrup |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911210590.XA CN110892987A (en) | 2017-11-05 | 2017-11-05 | Preparation method of wolfberry syrup |
CN201711074611.0A CN107868028A (en) | 2017-11-05 | 2017-11-05 | A kind of method that zeaxanthin acid dipalmitate is extracted in the raw material from liquid medlar |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711074611.0A Division CN107868028A (en) | 2017-11-05 | 2017-11-05 | A kind of method that zeaxanthin acid dipalmitate is extracted in the raw material from liquid medlar |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110892987A true CN110892987A (en) | 2020-03-20 |
Family
ID=61752986
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911217107.0A Pending CN110881650A (en) | 2017-11-05 | 2017-11-05 | Chinese wolfberry starch product |
CN201711074611.0A Pending CN107868028A (en) | 2017-11-05 | 2017-11-05 | A kind of method that zeaxanthin acid dipalmitate is extracted in the raw material from liquid medlar |
CN201911210590.XA Pending CN110892987A (en) | 2017-11-05 | 2017-11-05 | Preparation method of wolfberry syrup |
CN201911217110.2A Pending CN110810680A (en) | 2017-11-05 | 2017-11-05 | Eyesight-improving medlar beverage containing zeaxanthin |
CN201911217396.4A Pending CN111194921A (en) | 2017-11-05 | 2017-11-05 | Preparation method of Chinese wolfberry fruit paste |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911217107.0A Pending CN110881650A (en) | 2017-11-05 | 2017-11-05 | Chinese wolfberry starch product |
CN201711074611.0A Pending CN107868028A (en) | 2017-11-05 | 2017-11-05 | A kind of method that zeaxanthin acid dipalmitate is extracted in the raw material from liquid medlar |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911217110.2A Pending CN110810680A (en) | 2017-11-05 | 2017-11-05 | Eyesight-improving medlar beverage containing zeaxanthin |
CN201911217396.4A Pending CN111194921A (en) | 2017-11-05 | 2017-11-05 | Preparation method of Chinese wolfberry fruit paste |
Country Status (1)
Country | Link |
---|---|
CN (5) | CN110881650A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332366A (en) * | 2020-03-02 | 2021-09-03 | 张腾龙 | Application of medical composition in preparing medicine for treating xerophthalmia |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110746515B (en) * | 2019-10-28 | 2021-08-06 | 百瑞源枸杞股份有限公司 | Lycium barbarum polysaccharide, lycium barbarum red element and lycium barbarum polypeptide prepared by synchronous separation and preparation method thereof |
CN111467334A (en) * | 2020-04-20 | 2020-07-31 | 宁夏农林科学院枸杞工程技术研究所 | Method for preparing zeaxanthin dipalmitate high internal phase emulsion by using amyloid fiber-polysaccharide complex |
CN116326702A (en) * | 2023-02-23 | 2023-06-27 | 重庆瑞航生物科技有限公司 | Blueberry beverage with eye protection function and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103006899A (en) * | 2012-12-02 | 2013-04-03 | 陕西方舟制药有限公司 | Medlar general flavones extracting and purifying technology and medlar general flavone detecting method as well as applications of medlar general flavone |
WO2013123618A1 (en) * | 2012-02-22 | 2013-08-29 | Dsm Ip Assets B.V. | Process for manufacture of extract containing zeaxanthin and/or its esters |
CN105503681A (en) * | 2014-09-25 | 2016-04-20 | 赵军 | Preparation method of high purity Chinese wolfberry zeaxanthin palmitate |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101433635A (en) * | 2007-11-16 | 2009-05-20 | 北京因科瑞斯医药科技有限公司 | Composition with function for alleviating eyestrain and preparation method thereof |
CN103080238B (en) * | 2010-08-25 | 2016-01-20 | 帝斯曼知识产权资产管理有限公司 | For the manufacture of the method for the high extracting and enriching thing containing zeaxanthin and/or its ester |
CN102440385A (en) * | 2010-10-12 | 2012-05-09 | 陕西天富食品设备有限公司 | Health care matrimony vine vermicelli and preparation method thereof |
WO2013127255A1 (en) * | 2012-02-27 | 2013-09-06 | Dsm Ip Assets B.V. | Process for manufacture of highly enriched extract containing zeaxanthin and/or its esters |
CN102886153B (en) * | 2012-10-24 | 2015-12-02 | 周学义 | The extracting method of improving eyesight functional component in matrimony vine and the slag dregs of rice thereof |
CN103504435B (en) * | 2013-10-13 | 2016-08-17 | 全亚平 | Wolfberry bright eye beverage and production method thereof rich in zeaxanthin |
CN105614309A (en) * | 2014-11-03 | 2016-06-01 | 天津博莱恩科技发展有限公司 | Manufacturing method of Chinese wolfberry fruit paste |
CN105614859B (en) * | 2016-01-20 | 2018-09-14 | 银川回回香食品有限公司 | A kind of medlar oil and preparation method thereof |
CN106699625B (en) * | 2017-01-11 | 2018-09-11 | 上海璞菁生物科技有限公司 | The method that zeaxanthin is prepared from Chinese wolfberry fruit dregs |
-
2017
- 2017-11-05 CN CN201911217107.0A patent/CN110881650A/en active Pending
- 2017-11-05 CN CN201711074611.0A patent/CN107868028A/en active Pending
- 2017-11-05 CN CN201911210590.XA patent/CN110892987A/en active Pending
- 2017-11-05 CN CN201911217110.2A patent/CN110810680A/en active Pending
- 2017-11-05 CN CN201911217396.4A patent/CN111194921A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013123618A1 (en) * | 2012-02-22 | 2013-08-29 | Dsm Ip Assets B.V. | Process for manufacture of extract containing zeaxanthin and/or its esters |
CN103006899A (en) * | 2012-12-02 | 2013-04-03 | 陕西方舟制药有限公司 | Medlar general flavones extracting and purifying technology and medlar general flavone detecting method as well as applications of medlar general flavone |
CN105503681A (en) * | 2014-09-25 | 2016-04-20 | 赵军 | Preparation method of high purity Chinese wolfberry zeaxanthin palmitate |
Non-Patent Citations (2)
Title |
---|
刘志明等: "枸杞保健糖浆研制工艺", 《保鲜与加工》 * |
张兆旺: "《中药药剂学》", 31 March 2017, 中国中医药出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332366A (en) * | 2020-03-02 | 2021-09-03 | 张腾龙 | Application of medical composition in preparing medicine for treating xerophthalmia |
Also Published As
Publication number | Publication date |
---|---|
CN107868028A (en) | 2018-04-03 |
CN110810680A (en) | 2020-02-21 |
CN111194921A (en) | 2020-05-26 |
CN110881650A (en) | 2020-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105949163B (en) | The method for extraction and purification of anthocyanidin in a kind of Black Box Tracing pomace | |
CN110892987A (en) | Preparation method of wolfberry syrup | |
CN101607218B (en) | Corn steam explosion separation and endosperm multi-component co-production utilization technology thereof | |
CN102886153B (en) | The extracting method of improving eyesight functional component in matrimony vine and the slag dregs of rice thereof | |
CN107047921B (en) | Method for preparing protein powder and polypeptide powder by using various vinasse | |
CN103342692A (en) | Method for extracting blueberry anthocyanin | |
CN107513476A (en) | A kind of sweet yellow rice wine of health care half and its production technology | |
CN103130698B (en) | The method of zeaxanthin is extracted from matrimony vine, Chinese wolfberry fruit dregs | |
CN101948897A (en) | Method for extracting shinyleaf yellowhorn oil, shinyleaf yellowhorn polysaccharide and shinyleaf yellowhorn protolysate peptide from shinyleaf yellowhorn | |
CN103254320A (en) | Method for producing corn starch by utilizing enzymic method | |
CN102796610A (en) | Production technology for extracting eucommia oil and eucommia protein from eucommia kernels | |
CN111718821B (en) | Novel medlar fermented wine and brewing method thereof | |
CN101906129A (en) | Method for separating purified saponin | |
CN104774228A (en) | Method for preparing persimmon tannin from persimmon | |
CN110885730A (en) | Production method of Chinese wolfberry fruit wine | |
CN106810618A (en) | A kind of extraction from Chinese caterpillar fungus culture medium and the method for continuous polysaccharide enrichment | |
CN103073914A (en) | Method for extracting maize yellow pigment from maize protein | |
CN112604319A (en) | Citrus peel progressive extraction method and device | |
CN101390975A (en) | Extraction method of citrus active ingredient | |
CN108434182B (en) | Supercritical CO2Method for extracting seabuckthorn leaf polyphenol by fluid extraction technology | |
CN106820170A (en) | A kind of preparation method of kiwifruit peel soluble dietary fiber | |
CN109206528A (en) | A kind of fructus lycii functional component high-performance bio extracting method | |
CN112898444B (en) | Method for preparing muramyl polysaccharide by using ganoderma lucidum spore powder raffinate, product and application thereof | |
CN108753432A (en) | A kind of method that aqueous enzymatic method prepares granada seed oil | |
CN1508139A (en) | Process for extracting rubusoside of fruit of Gorsvenor Momordica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 750001 4-1-202, hongbaoxi garden, Ping'an West Street, Zhongning County, Zhongwei City, Ningxia Hui Autonomous Region Applicant after: Zhou Xueyi Address before: 750001 the Ningxia Hui Autonomous Region Yinchuan Xingqing District Zhongshan North Street Sun City Garden 1-4-301 Applicant before: Zhou Xueyi |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |